A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
Purpose The statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality analysis. The aim of this study was to improve the efficiency of full database screening using a prediction model‐based approach. Met...
Saved in:
| Published in | Pharmacoepidemiology and drug safety Vol. 27; no. 2; pp. 199 - 205 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Wiley Subscription Services, Inc
01.02.2018
John Wiley and Sons Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1053-8569 1099-1557 1099-1557 |
| DOI | 10.1002/pds.4364 |
Cover
| Abstract | Purpose
The statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality analysis. The aim of this study was to improve the efficiency of full database screening using a prediction model‐based approach.
Methods
A logistic regression‐based prediction model containing 5 candidate predictors was developed and internally validated using the Summary of Product Characteristics as the gold standard for the outcome. All drug‐ADR associations, with the exception of those related to vaccines, with a minimum of 3 reports formed the training data for the model. Performance was based on the area under the receiver operating characteristic curve (AUC). Results were compared with the current method of database screening based on the number of previously analyzed associations.
Results
A total of 25 026 unique drug‐ADR associations formed the training data for the model. The final model contained all 5 candidate predictors (number of reports, disproportionality, reports from healthcare professionals, reports from marketing authorization holders, Naranjo score). The AUC for the full model was 0.740 (95% CI; 0.734–0.747). The internal validity was good based on the calibration curve and bootstrapping analysis (AUC after bootstrapping = 0.739). Compared with the old method, the AUC increased from 0.649 to 0.740, and the proportion of potential signals increased by approximately 50% (from 12.3% to 19.4%).
Conclusions
A prediction model‐based approach can be a useful tool to create priority‐based listings for signal detection in databases consisting of spontaneous ADRs. |
|---|---|
| AbstractList | The statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality analysis. The aim of this study was to improve the efficiency of full database screening using a prediction model-based approach.
A logistic regression-based prediction model containing 5 candidate predictors was developed and internally validated using the Summary of Product Characteristics as the gold standard for the outcome. All drug-ADR associations, with the exception of those related to vaccines, with a minimum of 3 reports formed the training data for the model. Performance was based on the area under the receiver operating characteristic curve (AUC). Results were compared with the current method of database screening based on the number of previously analyzed associations.
A total of 25 026 unique drug-ADR associations formed the training data for the model. The final model contained all 5 candidate predictors (number of reports, disproportionality, reports from healthcare professionals, reports from marketing authorization holders, Naranjo score). The AUC for the full model was 0.740 (95% CI; 0.734-0.747). The internal validity was good based on the calibration curve and bootstrapping analysis (AUC after bootstrapping = 0.739). Compared with the old method, the AUC increased from 0.649 to 0.740, and the proportion of potential signals increased by approximately 50% (from 12.3% to 19.4%).
A prediction model-based approach can be a useful tool to create priority-based listings for signal detection in databases consisting of spontaneous ADRs. Purpose The statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality analysis. The aim of this study was to improve the efficiency of full database screening using a prediction model‐based approach. Methods A logistic regression‐based prediction model containing 5 candidate predictors was developed and internally validated using the Summary of Product Characteristics as the gold standard for the outcome. All drug‐ADR associations, with the exception of those related to vaccines, with a minimum of 3 reports formed the training data for the model. Performance was based on the area under the receiver operating characteristic curve (AUC). Results were compared with the current method of database screening based on the number of previously analyzed associations. Results A total of 25 026 unique drug‐ADR associations formed the training data for the model. The final model contained all 5 candidate predictors (number of reports, disproportionality, reports from healthcare professionals, reports from marketing authorization holders, Naranjo score). The AUC for the full model was 0.740 (95% CI; 0.734–0.747). The internal validity was good based on the calibration curve and bootstrapping analysis (AUC after bootstrapping = 0.739). Compared with the old method, the AUC increased from 0.649 to 0.740, and the proportion of potential signals increased by approximately 50% (from 12.3% to 19.4%). Conclusions A prediction model‐based approach can be a useful tool to create priority‐based listings for signal detection in databases consisting of spontaneous ADRs. PurposeThe statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality analysis. The aim of this study was to improve the efficiency of full database screening using a prediction model-based approach.MethodsA logistic regression-based prediction model containing 5 candidate predictors was developed and internally validated using the Summary of Product Characteristics as the gold standard for the outcome. All drug-ADR associations, with the exception of those related to vaccines, with a minimum of 3 reports formed the training data for the model. Performance was based on the area under the receiver operating characteristic curve (AUC). Results were compared with the current method of database screening based on the number of previously analyzed associations.ResultsA total of 25 026 unique drug-ADR associations formed the training data for the model. The final model contained all 5 candidate predictors (number of reports, disproportionality, reports from healthcare professionals, reports from marketing authorization holders, Naranjo score). The AUC for the full model was 0.740 (95% CI; 0.734-0.747). The internal validity was good based on the calibration curve and bootstrapping analysis (AUC after bootstrapping = 0.739). Compared with the old method, the AUC increased from 0.649 to 0.740, and the proportion of potential signals increased by approximately 50% (from 12.3% to 19.4%).ConclusionsA prediction model-based approach can be a useful tool to create priority-based listings for signal detection in databases consisting of spontaneous ADRs. The statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality analysis. The aim of this study was to improve the efficiency of full database screening using a prediction model-based approach.PURPOSEThe statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality analysis. The aim of this study was to improve the efficiency of full database screening using a prediction model-based approach.A logistic regression-based prediction model containing 5 candidate predictors was developed and internally validated using the Summary of Product Characteristics as the gold standard for the outcome. All drug-ADR associations, with the exception of those related to vaccines, with a minimum of 3 reports formed the training data for the model. Performance was based on the area under the receiver operating characteristic curve (AUC). Results were compared with the current method of database screening based on the number of previously analyzed associations.METHODSA logistic regression-based prediction model containing 5 candidate predictors was developed and internally validated using the Summary of Product Characteristics as the gold standard for the outcome. All drug-ADR associations, with the exception of those related to vaccines, with a minimum of 3 reports formed the training data for the model. Performance was based on the area under the receiver operating characteristic curve (AUC). Results were compared with the current method of database screening based on the number of previously analyzed associations.A total of 25 026 unique drug-ADR associations formed the training data for the model. The final model contained all 5 candidate predictors (number of reports, disproportionality, reports from healthcare professionals, reports from marketing authorization holders, Naranjo score). The AUC for the full model was 0.740 (95% CI; 0.734-0.747). The internal validity was good based on the calibration curve and bootstrapping analysis (AUC after bootstrapping = 0.739). Compared with the old method, the AUC increased from 0.649 to 0.740, and the proportion of potential signals increased by approximately 50% (from 12.3% to 19.4%).RESULTSA total of 25 026 unique drug-ADR associations formed the training data for the model. The final model contained all 5 candidate predictors (number of reports, disproportionality, reports from healthcare professionals, reports from marketing authorization holders, Naranjo score). The AUC for the full model was 0.740 (95% CI; 0.734-0.747). The internal validity was good based on the calibration curve and bootstrapping analysis (AUC after bootstrapping = 0.739). Compared with the old method, the AUC increased from 0.649 to 0.740, and the proportion of potential signals increased by approximately 50% (from 12.3% to 19.4%).A prediction model-based approach can be a useful tool to create priority-based listings for signal detection in databases consisting of spontaneous ADRs.CONCLUSIONSA prediction model-based approach can be a useful tool to create priority-based listings for signal detection in databases consisting of spontaneous ADRs. |
| Author | Hunsel, Florence P.A.M. Puijenbroek, Eugène P. Scholl, Joep H.G. Hak, Eelko |
| AuthorAffiliation | 1 Netherlands Pharmacovigilance Centre Lareb 's‐Hertogenbosch The Netherlands 2 PharmacoTherapy, ‐Epidemiology and ‐Economics, Groningen Research Institute of Pharmacy University of Groningen The Netherlands |
| AuthorAffiliation_xml | – name: 1 Netherlands Pharmacovigilance Centre Lareb 's‐Hertogenbosch The Netherlands – name: 2 PharmacoTherapy, ‐Epidemiology and ‐Economics, Groningen Research Institute of Pharmacy University of Groningen The Netherlands |
| Author_xml | – sequence: 1 givenname: Joep H.G. orcidid: 0000-0002-9222-5965 surname: Scholl fullname: Scholl, Joep H.G. email: j.scholl@lareb.nl organization: University of Groningen – sequence: 2 givenname: Florence P.A.M. orcidid: 0000-0001-8965-3224 surname: Hunsel fullname: Hunsel, Florence P.A.M. organization: Netherlands Pharmacovigilance Centre Lareb – sequence: 3 givenname: Eelko surname: Hak fullname: Hak, Eelko organization: University of Groningen – sequence: 4 givenname: Eugène P. orcidid: 0000-0002-2236-1398 surname: Puijenbroek fullname: Puijenbroek, Eugène P. organization: University of Groningen |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29271017$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kdtuFSEUhompsQdNfAJD4k29mC3MMMxwY9K0npJGTew9YWCxN80MjDDTZide-Ag-o08i011PjXoDhPWx-Pk4RHs-eEDoMSUrSkj5fDRpxSrO7qEDSoQoaF03e8u6roq25mIfHaZ0SUiuCfYA7ZeibCihzQH6fILHCMbpyQWPh2Cg__bla6cSGKz6dYhu2gzYhoh1GMZ5gpjLKiWXpkwYNamFxUlHAO_8GgeLlbmCmDdNnNc4grrpnbDzeNoAfgd5jL3yJj1E963qEzy6nY_QxauXF6dvivP3r9-enpwXuiaMFVZpbRjwkpeVKMEoy63toK1IoynlVWWhqShVBKqu45q23JqutayjuhRZwRF6tms7-1Ftr1XfyzG6QcWtpEQuAmUWKBeBmX2xY8e5G8Bo8FNUv_ignPyz4t1GrsOVrFvKWrFcdnzbIIZPM6RJDi5p6PODIcxJUtEIwZscOKNP76CXYY4-m8iUqNoMMZGpJ78n-hnlxx9mYLUDdAwpRbBSu0ktznNA1__tjcd3DvxHR7FDr10P239y8sPZxxv-O8qnz4E |
| CitedBy_id | crossref_primary_10_5487_TR_2019_35_4_319 crossref_primary_10_1007_s40801_022_00301_x crossref_primary_10_1007_s40264_019_00897_0 crossref_primary_10_3820_jjpe_25_56 crossref_primary_10_1002_pds_4790 crossref_primary_10_1155_2021_6033860 crossref_primary_10_9728_dcs_2024_25_12_3663 crossref_primary_10_1002_pds_5610 crossref_primary_10_1109_ACCESS_2020_3029446 crossref_primary_10_1002_pds_5246 crossref_primary_10_1080_14740338_2023_2182289 crossref_primary_10_1002_pds_5553 crossref_primary_10_1016_j_hlpt_2023_100743 crossref_primary_10_1177_20420986231219472 crossref_primary_10_1097_ACI_0000000000000454 crossref_primary_10_1016_j_tips_2021_09_007 crossref_primary_10_1007_s40264_023_01327_y crossref_primary_10_1111_jcpt_13086 crossref_primary_10_3389_fdsfr_2023_1120135 |
| Cites_doi | 10.2165/00002018-199920020-00002 10.1007/s40264-013-0131-x 10.1002/pds.2092 10.1002/pds.4115 10.1007/s40264-014-0204-5 10.1002/pds.4236 10.1007/s10618-009-0152-3 10.1016/0895-4356(92)90158-J 10.1002/pds.3687 10.1002/pds.3395 10.1007/s40264-016-0405-1 10.1007/s40264-015-0289-5 10.1002/pds.3529 10.2165/00002018-200225060-00001 10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O 10.1080/01621459.1992.10475190 10.1002/pds.3226 10.1038/clpt.1981.154 10.1002/pds.1742 10.1592/phco.24.8.743.36068 10.1007/s40264-014-0237-9 |
| ContentType | Journal Article |
| Copyright | 2017 The Authors. Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons Ltd. Copyright © 2018 John Wiley & Sons, Ltd. |
| Copyright_xml | – notice: 2017 The Authors. Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons Ltd. – notice: Copyright © 2018 John Wiley & Sons, Ltd. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 5PM ADTOC UNPAY |
| DOI | 10.1002/pds.4364 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | Scholl et al |
| EISSN | 1099-1557 |
| EndPage | 205 |
| ExternalDocumentID | 10.1002/pds.4364 PMC5814895 29271017 10_1002_pds_4364 PDS4364 |
| Genre | article Comparative Study Research Support, Non-U.S. Gov't Evaluation Study Journal Article |
| GeographicLocations | Netherlands |
| GeographicLocations_xml | – name: Netherlands |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 24P 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA GWYGA H.X HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES M6Q MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V8K W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWP WXI WXSBR XG1 XV2 YCJ ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c5044-faccd4e6262392edaf6ffbe8307c11633fe7311a0e3bb6c186fdb8f4b1c29053 |
| IEDL.DBID | 24P |
| ISSN | 1053-8569 1099-1557 |
| IngestDate | Sun Oct 26 04:14:32 EDT 2025 Thu Aug 21 18:12:41 EDT 2025 Fri Sep 05 12:58:06 EDT 2025 Tue Oct 07 06:06:35 EDT 2025 Thu Apr 03 07:01:44 EDT 2025 Thu Apr 24 22:55:57 EDT 2025 Wed Oct 01 05:03:24 EDT 2025 Wed Jan 22 16:36:28 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | signal detection prediction model pharmacovigilance adverse drug reaction pharmacoepidemiology |
| Language | English |
| License | Attribution http://creativecommons.org/licenses/by/4.0 2017 The Authors. Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5044-faccd4e6262392edaf6ffbe8307c11633fe7311a0e3bb6c186fdb8f4b1c29053 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 PRIOR POSTINGS / PRESENTATIONS: Parts of this manuscript have been presented as an abstract at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2016 (ICPE). |
| ORCID | 0000-0002-2236-1398 0000-0002-9222-5965 0000-0001-8965-3224 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpds.4364 |
| PMID | 29271017 |
| PQID | 1993877349 |
| PQPubID | 105383 |
| PageCount | 7 |
| ParticipantIDs | unpaywall_primary_10_1002_pds_4364 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5814895 proquest_miscellaneous_1979967731 proquest_journals_1993877349 pubmed_primary_29271017 crossref_citationtrail_10_1002_pds_4364 crossref_primary_10_1002_pds_4364 wiley_primary_10_1002_pds_4364_PDS4364 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | February 2018 |
| PublicationDateYYYYMMDD | 2018-02-01 |
| PublicationDate_xml | – month: 02 year: 2018 text: February 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Bethesda – name: Hoboken |
| PublicationTitle | Pharmacoepidemiology and drug safety |
| PublicationTitleAlternate | Pharmacoepidemiol Drug Saf |
| PublicationYear | 2018 |
| Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
| References | 2015; 24 2002; 25 2010; 20 2015; 38 2013; 22 2017; 26 2011 2010 2004; 24 2011; 20 2014; 37 2007 1996 1997; 16 1999; 20 2016; 39 1992; 87 1981; 30 1992; 45 2012; 21 2016; 25 2014; 23 2009; 18 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 Raine JM (e_1_2_8_3_1) 2007 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 Hunsel F (e_1_2_8_8_1) 2015; 24 e_1_2_8_20_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 Scholl JH (e_1_2_8_21_1) 2015; 38 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 |
| References_xml | – year: 2011 – volume: 38 start-page: 986 issue: 10 year: 2015 article-title: Case‐by‐case assessment of ICSRs from marketing authorization holders: a pilot study publication-title: Drug Saf – volume: 45 start-page: 1177 issue: 10 year: 1992 end-page: 1184 article-title: Serum sickness‐like reactions to cefaclor publication-title: J Clin Epidemiol – volume: 24 start-page: 152 issue: 2 year: 2015 end-page: 158 article-title: Adverse drug reaction reports of patients and healthcare professionals‐differences in reported information publication-title: Pharmacoepidemiol Drug Saf – volume: 18 start-page: 427 issue: 6 year: 2009 end-page: 436 article-title: Quantitative signal detection using spontaneous ADR reporting publication-title: Pharmacoepidemiol Drug Saf – volume: 23 start-page: 195 issue: 2 year: 2014 end-page: 207 article-title: Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases publication-title: Pharmacoepidemiol Drug Saf – year: 2007 – volume: 25 start-page: 1361 issue: 12 year: 2016 end-page: 1367 article-title: The value of time‐to‐onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands publication-title: Pharmacoepidemiol Drug Saf – year: 1996 – volume: 37 start-page: 1047 issue: 12 year: 2014 end-page: 1057 article-title: Use of logistic regression to combine two causality criteria for signal detection in vaccine spontaneous report data publication-title: Drug Saf – volume: 22 start-page: 302 issue: 3 year: 2013 end-page: 305 article-title: Evaluation of FDA safety‐related drug label changes in 2010 publication-title: Pharmacoepidemiol Drug Saf – volume: 20 start-page: 286 issue: 3 year: 2011 end-page: 291 article-title: The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case‐control study publication-title: Pharmacoepidemiol Drug Saf – volume: 37 start-page: 65 issue: 1 year: 2014 end-page: 77 article-title: vigiGrade: a tool to identify well‐documented individual case reports and highlight systematic data quality issues publication-title: Drug Saf – volume: 21 start-page: 603 issue: 6 year: 2012 end-page: 610 article-title: Using time‐to‐onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept study publication-title: Pharmacoepidemiol Drug Saf – volume: 16 start-page: 965 issue: 9 year: 1997 end-page: 980 article-title: A comparison of goodness‐of‐fit tests for the logistic regression model publication-title: Stat Med – volume: 39 start-page: 469 issue: 6 year: 2016 end-page: 490 article-title: Good signal detection practices: evidence from IMI PROTECT publication-title: Drug Saf – volume: 30 start-page: 239 issue: 2 year: 1981 end-page: 245 article-title: A method for estimating the probability of adverse drug reactions publication-title: Clin Pharmacol Ther – volume: 38 start-page: 577 issue: 6 year: 2015 end-page: 587 article-title: Comparison of statistical signal detection methods within and across spontaneous reporting databases publication-title: Drug Saf – year: 2010 – volume: 20 start-page: 109 issue: 2 year: 1999 end-page: 117 article-title: The medical dictionary for regulatory activities (MedDRA) publication-title: Drug Saf – volume: 20 start-page: 361 issue: 3 year: 2010 end-page: 387 article-title: Temporal pattern discovery in longitudinal electronic patient records publication-title: Data Min Knowl Discov – volume: 37 start-page: 617 issue: 8 year: 2014 end-page: 628 article-title: Improved statistical signal detection in pharmacovigilance by combining multiple strength‐of‐evidence aspects in vigiRank publication-title: Drug Saf – volume: 25 start-page: 381 issue: 6 year: 2002 end-page: 392 article-title: Use of screening algorithms and computer systems to efficiently signal higher‐than‐expected combinations of drugs and events in the US FDA's spontaneous reports database publication-title: Drug Saf – volume: 24 start-page: 743 issue: 6 year: 2004 end-page: 749 article-title: Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration publication-title: Pharmacotherapy – volume: 87 start-page: 178 issue: 417 year: 1992 end-page: 183 article-title: Generalized collinearity diagnostics publication-title: J Am Stat Assoc – volume: 26 start-page: 977 issue: 8 year: 2017 end-page: 983 article-title: The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015 publication-title: Pharmacoepidemiol Drug Saf – volume: 24 start-page: 442 issue: S1 year: 2015 article-title: Experiences with a computer‐assisted database screening tool at The Netherlands Pharmacovigilance Centre Lareb publication-title: Pharmacoepidemiol Drug Saf – ident: e_1_2_8_12_1 doi: 10.2165/00002018-199920020-00002 – volume-title: Risk Management: A European Regulatory View year: 2007 ident: e_1_2_8_3_1 – ident: e_1_2_8_10_1 doi: 10.1007/s40264-013-0131-x – ident: e_1_2_8_5_1 doi: 10.1002/pds.2092 – ident: e_1_2_8_23_1 doi: 10.1002/pds.4115 – ident: e_1_2_8_9_1 doi: 10.1007/s40264-014-0204-5 – ident: e_1_2_8_17_1 doi: 10.1002/pds.4236 – ident: e_1_2_8_22_1 doi: 10.1007/s10618-009-0152-3 – ident: e_1_2_8_7_1 doi: 10.1016/0895-4356(92)90158-J – ident: e_1_2_8_16_1 doi: 10.1002/pds.3687 – ident: e_1_2_8_4_1 doi: 10.1002/pds.3395 – ident: e_1_2_8_13_1 – ident: e_1_2_8_6_1 doi: 10.1007/s40264-016-0405-1 – ident: e_1_2_8_2_1 – ident: e_1_2_8_20_1 doi: 10.1007/s40264-015-0289-5 – ident: e_1_2_8_26_1 doi: 10.1002/pds.3529 – ident: e_1_2_8_15_1 doi: 10.2165/00002018-200225060-00001 – ident: e_1_2_8_19_1 – volume: 38 start-page: 986 issue: 10 year: 2015 ident: e_1_2_8_21_1 article-title: Case‐by‐case assessment of ICSRs from marketing authorization holders: a pilot study publication-title: Drug Saf – ident: e_1_2_8_24_1 doi: 10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O – ident: e_1_2_8_18_1 doi: 10.1080/01621459.1992.10475190 – ident: e_1_2_8_14_1 doi: 10.1002/pds.3226 – ident: e_1_2_8_11_1 doi: 10.1038/clpt.1981.154 – volume: 24 start-page: 442 issue: 1 year: 2015 ident: e_1_2_8_8_1 article-title: Experiences with a computer‐assisted database screening tool at The Netherlands Pharmacovigilance Centre Lareb publication-title: Pharmacoepidemiol Drug Saf – ident: e_1_2_8_25_1 doi: 10.1002/pds.1742 – ident: e_1_2_8_27_1 doi: 10.1592/phco.24.8.743.36068 – ident: e_1_2_8_28_1 doi: 10.1007/s40264-014-0237-9 |
| SSID | ssj0009994 |
| Score | 2.29621 |
| Snippet | Purpose
The statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on... The statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality... PurposeThe statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on... |
| SourceID | unpaywall pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 199 |
| SubjectTerms | adverse drug reaction Adverse Drug Reaction Reporting Systems - statistics & numerical data Algorithms Data Mining - methods Databases, Factual - statistics & numerical data Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - prevention & control Humans Logistic Models Multivariate Analysis Netherlands - epidemiology Original Report Original Reports pharmacoepidemiology Pharmacovigilance prediction model ROC Curve signal detection |
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELege4CX8R8KAxmEystSNbFjJ48VME1ITJXopPEU2Y69VZS0ahtNRTzwEfiMfBLu7DRbGSDEUyX74ibxnf273Pl3hLzUAws4VbPI5VpEXAsWaWbyKDZlYhnPtCzxoPD7I3F4zN-dpCfNBzc8CxP4IdoPbmgZfr1GA5-XLqzzTXQ_gZZlnzPBr5MdkQIW75Cd46PR8KMPcaYsylJf0w6jPxFsnHLDPnvp0u396ArIvJoreaOu5mp9rqbTbTzrN6SDW6TYPErIQ_nUr1e6b778wvL4_896m-w2WJUOg3LdIddsdZf0RoHser1Pxxdnt5b7tEdHFzTY63vk65DOFxgGwqmnvuLOj2_fcdcsqZqezhaT1dlnCpiZmqayBHQDlEe9KylmrqIshWUNXG3YYOnMUYXlo6GxXNSnFOCuH3tJJxUFHEsvHV6-T8YHb8evD6Om1kNk0gHnkVPGlNyCe5UAYrOlcsI5bTNYgkwMmJE5K1kcq4FlWgsTZ8KVOnNcxybJYaofkE41q-wjQq2wcc6FNdDMwfVX4LI6rrQFKAvep-ySV5sJL0zDg47lOKZFYHBOCnjTBb7pLnneSs4D98dvZPY2OlM01r8sMCkyk5LxHIZou8FuMRijKjurUUaCqwlCcZc8DCrW_kmSJzL2tyq3lK8VQE7w7Z5qcua5wdMM_Ns87ZIXrZr-5d57Xun-KFCM3nzA38f_MtoTchPAZBYy2vdIZ7Wo7VMAbCv9rLHKn-wJRrA priority: 102 providerName: Unpaywall |
| Title | A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpds.4364 https://www.ncbi.nlm.nih.gov/pubmed/29271017 https://www.proquest.com/docview/1993877349 https://www.proquest.com/docview/1979967731 https://pubmed.ncbi.nlm.nih.gov/PMC5814895 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.4364 |
| UnpaywallVersion | publishedVersion |
| Volume | 27 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1053-8569 databaseCode: DR2 dateStart: 19960101 customDbUrl: isFulltext: true eissn: 1099-1557 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009994 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtNAEF5Be4AL4p_QUi0IhUtNs9712j5GlKpCorIglcrJ2t82UnCiOFEViQOPwDPyJMysHYeogLjY0u54bXlmdr-xZ78h5LUeOMCpmkc-1zISWvJIc5NHzNjYcZHp1OJG4Y9n8vRcfLhILtqsStwL0_BDdB_c0DPCfI0OrnR9tCENndn6reBS3Ca7DGAMWncsig3hbh6KIAJ84FGWyHxNPDuIj9ZXbi9FN_DlzTTJO8tqplbXajLZhrJhLTq5T-61IJIOG60_ILdc9ZD0i4aFenVIR5tNVfUh7dNiw0-9ekS-Delsjv9nUCc0lML5-f0HLmeWqsnldD5eXH2lAGapaUs-QDdgbDQISzGlFGUpzDcQA8PKR6eeKqzrDI12vrykgEPD2DUdVxQAJv1tV_FjMjp5P3p3GrVFGCKTDISIvDLGCgdxTwxQylnlpffaZTA3GAZgjnuXcsbUwHGtpWGZ9FZnXmhm4hxe_hOyU00r94xQJx3LhXQGmgXE5ApiSS-UdoAxISxMe-TNWh2laQnKsU7GpGyoleMSFFei4nrkZSc5a0g5_iCzv9Zo2bplXWK2YpamXOQwRNcNDoV_SVTlpkuUSSEGBCHWI08bA-huEudxysKjplum0QkgWfd2TzW-CqTdSQaBZ570yKvOiP7x7P1gXX8VKIvjz3h-_r-Ce-QuIL2sSTffJzuL-dK9ADS10AfBbeB4_Ck-ILvnZ8Xwyy-ORiTS |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LbxMxELZKOZQLKu_QAgahcOm28drrXYtTBVQB2ioSQeptZXvtNlLYRHkIReLAT-A38kuY8T5CVECcVrJnvdbOjP2NH98Q8tL0HOBUwyOvjIyEkTwy3KqI2SJ2XGQmLfCi8Nm57H8WHy6Siy3yurkLU_FDtAtu6BlhvEYHxwXpozVr6LSYHwouxQ1yU0gmMfKKxWDNuKtCFkTADzzKEqka5tlefNS8uTkXXQOY189J7izLqV591ePxJpYNk9HJLrldo0h6XKn9Dtly5V3SHVQ01KsDOlzfqpof0C4drAmqV_fIt2M6neEGDSqFhlw4P7__wPmsoHp8OZmNFldfKKBZauucD1ANIBstoqB4phRlKQw4EATD1EcnnmpM7AyFxWx5SQGIhrbndFRSQJj0t2vF98nw5N3wTT-qszBENukJEXltbSEcBD4xYClXaC-9Ny6DwcEyQHPcu5QzpnuOGyMty6QvTOaFYTZW8PMfkO1yUrpHhDrpmBLSWSgWEJRrCCa90MYByIS4MO2QV406clszlGOijHFecSvHOSguR8V1yPNWclqxcvxBZr_RaF775TzH44pZmnKhoIm2GjwKt0l06SZLlEkhCAQh1iEPKwNoPxKrOGWhq-mGabQCyNa9WVOOrgJrd5JB5KmSDnnRGtE_-t4N1vVXgXzw9hM-H_-v4DOy0x-enean788_7pFbAPuy6uz5PtlezJbuCUCrhXkaXOgXMnklpQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4tiwRceD8KCxiEymXTbWLHScRpRamW16qCIu0BKfJzt6KkUdsIFXHgJ_Ab-SWM8yplASFOkeyJ48Qz9jfx-BuAR7JvEKdK6tlEco9JTj1JVeL5SgeGslhG2h0Ufn3ID96xF0fh0RY8ac7CVPwQ7Q83ZxnlfO0M3OTa7q1ZQ3O96DHK2Rk4y8IkdvF8gzdr7ihEPuWWMmqZF4c8aZhn-8Fec-fmWnQKYJ6OkzxfZLlYfRLT6SaWLRej4SV437xGFYPyoVcsZU99_oXh8T_f8zJcrEEq2a-06gpsmewqdEcVy_Vql4zXh7YWu6RLRmv-69U1-LJP8rnb_3FjTspUO9-_fnPLpSZiejybT5YnHwmCZaLqlBJYjRjeKZwmLmTVyRKcz9DHxpWVzCwRLm80Fup5cUwQ55ZtL8gkIwhgyU-nlq_DePhs_PTAq5M8eCrsM-ZZoZRmBv2qAKGa0cJya6WJce5RPoJFak1EfV_0DZWSKz_mVsvYMumrIMGxvQHb2Swzt4AYbvyEcaOwmKHPL9BXtUxIgxgW3c6oA4-b0U5VTYDu8nBM04q6OUjxS6fuS3fgQSuZV6Qfv5HZaRQmrc1-kbpoyDiKKEuwibYaDdbtwojMzAonE6GPiUJ-B25W-tU-JEiCyC-7Gm1oXivgyMA3a7LJSUkKHsbo2CZhBx62OvqXvndLjfujQDoavHXX2_8qeB_OjQbD9NXzw5d34AKCyriKbN-B7eW8MHcRuC3lvdJAfwBzW0W0 |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELege4CX8R8KAxmEystSNbFjJ48VME1ITJXopPEU2Y69VZS0ahtNRTzwEfiMfBLu7DRbGSDEUyX74ibxnf273Pl3hLzUAws4VbPI5VpEXAsWaWbyKDZlYhnPtCzxoPD7I3F4zN-dpCfNBzc8CxP4IdoPbmgZfr1GA5-XLqzzTXQ_gZZlnzPBr5MdkQIW75Cd46PR8KMPcaYsylJf0w6jPxFsnHLDPnvp0u396ArIvJoreaOu5mp9rqbTbTzrN6SDW6TYPErIQ_nUr1e6b778wvL4_896m-w2WJUOg3LdIddsdZf0RoHser1Pxxdnt5b7tEdHFzTY63vk65DOFxgGwqmnvuLOj2_fcdcsqZqezhaT1dlnCpiZmqayBHQDlEe9KylmrqIshWUNXG3YYOnMUYXlo6GxXNSnFOCuH3tJJxUFHEsvHV6-T8YHb8evD6Om1kNk0gHnkVPGlNyCe5UAYrOlcsI5bTNYgkwMmJE5K1kcq4FlWgsTZ8KVOnNcxybJYaofkE41q-wjQq2wcc6FNdDMwfVX4LI6rrQFKAvep-ySV5sJL0zDg47lOKZFYHBOCnjTBb7pLnneSs4D98dvZPY2OlM01r8sMCkyk5LxHIZou8FuMRijKjurUUaCqwlCcZc8DCrW_kmSJzL2tyq3lK8VQE7w7Z5qcua5wdMM_Ns87ZIXrZr-5d57Xun-KFCM3nzA38f_MtoTchPAZBYy2vdIZ7Wo7VMAbCv9rLHKn-wJRrA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+prediction+model%E2%80%90based+algorithm+for+computer%E2%80%90assisted+database+screening+of+adverse+drug+reactions+in+the+Netherlands&rft.jtitle=Pharmacoepidemiology+and+drug+safety&rft.au=Scholl%2C+Joep+H.G.&rft.au=Hunsel%2C+Florence+P.A.M.&rft.au=Hak%2C+Eelko&rft.au=Puijenbroek%2C+Eug%C3%A8ne+P.&rft.date=2018-02-01&rft.issn=1053-8569&rft.eissn=1099-1557&rft.volume=27&rft.issue=2&rft.spage=199&rft.epage=205&rft_id=info:doi/10.1002%2Fpds.4364&rft.externalDBID=10.1002%252Fpds.4364&rft.externalDocID=PDS4364 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-8569&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-8569&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-8569&client=summon |